Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets

J Paccou1, M Brazier, R Mentaverri

  • 1Department of Rheumatology, University Hospital of Amiens, FR-80054 Amiens, France. julienpaccou@yahoo.fr

Atherosclerosis
|June 19, 2012
PubMed

Insights

Rheumatoid arthritis (RA) patients experience accelerated vascular calcification due to specific inflammatory mediators, not just general inflammation. This review explores RA-associated vascular calcification and potential therapeutic targets.

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Immunology

Background:

  • Rheumatoid arthritis (RA) significantly elevates cardiovascular disease (CVD) risk.
  • Conventional CVD risk factors do not fully account for excess mortality in RA patients.
  • Vascular calcification is a key contributor to CVD in RA.

Purpose of the Study:

  • To review current understanding of vascular calcification prevalence in RA.
  • To explore the pathophysiological mechanisms driving vascular calcification in RA.
  • To identify potential therapeutic targets for mitigating vascular calcification in RA.

Main Methods:

  • Literature review of recent studies on vascular calcification in rheumatoid arthritis.
  • Analysis of pathophysiological aspects, focusing on specific mediators.
  • Discussion of emerging therapeutic strategies.

Main Results:

  • RA patients exhibit earlier and more widespread vascular calcification than controls.
  • Proinflammatory cytokines, rather than global inflammation, are implicated in RA vascular calcification pathogenesis.
  • Specific molecular pathways contributing to calcification are being elucidated.

Conclusions:

  • Vascular calcification is a significant, accelerated complication in RA.
  • Targeting specific inflammatory pathways may reduce cardiovascular risk in RA patients.
  • Further research is needed to develop effective interventions against RA-associated vascular calcification.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...